Data sourcesSEC Form 416m ago
House PTR16m ago
SEC 13F15m ago
Robinhood Chain15m ago
Public companyFoghorn Therapeutics Inc.
FHTXCIK 0001822462
Price$1.87
1 year-53.2%
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score20
Connections with evidence7
FHTX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 12 | | FHTXFoghorn Therapeutics Inc. Grant or award | A | $114K 28.0K sh | Jun 24, 2026 | Jun 25, 2026 |
| 12 | | FHTXFoghorn Therapeutics Inc. Grant or award | A | $114K 28.0K sh | Jun 24, 2026 | Jun 25, 2026 traded Jun 24, 2026 | +1d | SEC Form 4 | |
| 20 | GAGottschalk AdrianDirector, Chief Executive Officer | FHTXFoghorn Therapeutics Inc. Gift | G | — 59.2K sh | Apr 10, 2026 | Apr 13, 2026 traded Apr 10, 2026 | +3d | SEC Form 4 | |
| 20 | GAGottschalk AdrianDirector, Chief Executive Officer | FHTXFoghorn Therapeutics Inc. Gift | G | — 47.5K sh | Apr 9, 2026 | Apr 13, 2026 traded Apr 9, 2026 | +4d | SEC Form 4 | |
| 20 | GAGottschalk AdrianDirector, Chief Executive Officer | FHTXFoghorn Therapeutics Inc. Gift | G | — 59.2K sh | Apr 10, 2026 | Apr 13, 2026 traded Apr 10, 2026 | +3d | SEC Form 4 | |
| 12 | GAGottschalk AdrianDirector, Chief Executive Officer | FHTXFoghorn Therapeutics Inc. Gift | G | — 47.5K sh | Apr 9, 2026 | Apr 13, 2026 traded Apr 9, 2026 | +4d | SEC Form 4 | |
| 18 | GAGottschalk AdrianDirector, Chief Executive Officer | FHTXFoghorn Therapeutics Inc. Grant or award | A | $5.62M 1.07M sh | Feb 5, 2026 | Feb 6, 2026 traded Feb 5, 2026 | +1d | SEC Form 4 | |
| 18 | CCCosta CarlosChief People Officer | FHTXFoghorn Therapeutics Inc. Grant or award | A | $1.31M 230.0K sh | Jan 30, 2026 | Feb 2, 2026 traded Jan 30, 2026 | +3d | SEC Form 4 | |
| 15 | RARivkin AnnaChief Business Officer | FHTXFoghorn Therapeutics Inc. Grant or award | A | $942K 165.0K sh | Jan 30, 2026 | Feb 2, 2026 traded Jan 30, 2026 | +3d | SEC Form 4 | |
Chief Business Officer · Feb 2, 2026